We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$392M
AUM Growth
+$54.2M
Cap. Flow
+$20.5M
Cap. Flow %
5.24%
Top 10 Hldgs %
7.44%
Holding
1,089
New
425
Increased
148
Reduced
117
Closed
399

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$1.74M
2
DVN icon
Devon Energy
DVN
+$1.72M
3
FE icon
FirstEnergy
FE
+$1.51M
4
MTDR icon
Matador Resources
MTDR
+$1.38M
5
V icon
Visa
V
+$1.31M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.55%
2 Technology 16.38%
3 Healthcare 12.13%
4 Industrials 11.68%
5 Financials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
226
Immunovant
IMVT
$8.09B
$612K 0.16%
+14,534
New +$535K
CROX icon
227
Crocs
CROX
$6.69B
$612K 0.16%
6,550
+1,017
+18% +$93.9K
BKR icon
228
Baker Hughes
BKR
$56.8B
$609K 0.16%
+17,825
New +$608K
CPA icon
229
Copa Holdings
CPA
$5.56B
$609K 0.16%
5,725
-6,508
-53% -$595K
GLNG icon
230
Golar LNG
GLNG
$4.95B
$608K 0.16%
+26,441
New +$593K
ETRN
231
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$608K 0.16%
59,701
+356
+0.6% +$3.35K
AVNT icon
232
Avient
AVNT
$3.45B
$607K 0.15%
+14,607
New +$510K
BNY
233
Bank of New York Mellon
BNY
$108B
$604K 0.15%
+11,597
New +$534K
MRO
234
DELISTED
Marathon Oil Corporation
MRO
$603K 0.15%
24,975
+13,252
+113% +$341K
INGR icon
235
Ingredion
INGR
$6.38B
$602K 0.15%
+5,543
New +$556K
REGN icon
236
Regeneron Pharmaceuticals
REGN
$68.8B
$594K 0.15%
676
+363
+116% +$299K
NUE icon
237
Nucor
NUE
$56.4B
$588K 0.15%
+3,379
New +$536K
NTRS icon
238
Northern Trust
NTRS
$22.2B
$587K 0.15%
+6,960
New +$515K
XYL icon
239
Xylem
XYL
$28.5B
$586K 0.15%
+5,124
New +$511K
WMB icon
240
Williams Companies
WMB
$90.5B
$585K 0.15%
16,803
+4,781
+40% +$168K
IBKR icon
241
Interactive Brokers
IBKR
$40.9B
$584K 0.15%
28,184
+15,236
+118% +$312K
KBR icon
242
KBR
KBR
$4.68B
$583K 0.15%
10,523
-12,546
-54% -$692K
CTVA icon
243
Corteva
CTVA
$59.7B
$582K 0.15%
+12,144
New +$579K
NTLA icon
244
Intellia Therapeutics
NTLA
$1.5B
$580K 0.15%
19,038
+8,282
+77% +$238K
TD icon
245
Toronto Dominion Bank
TD
$198B
$580K 0.15%
8,974
+3,901
+77% +$234K
EQR icon
246
Equity Residential
EQR
$25.4B
$578K 0.15%
+9,455
New +$547K
INFY icon
247
Infosys
INFY
$45B
$578K 0.15%
+31,442
New +$547K
OZK icon
248
Bank OZK
OZK
$5.49B
$577K 0.15%
11,577
-1,393
-11% -$57.4K
RAMP icon
249
LiveRamp
RAMP
$2.29B
$576K 0.15%
+15,203
New +$489K
TTMI icon
250
TTM Technologies
TTMI
$13.6B
$575K 0.15%
36,364
+18,267
+101% +$254K

Similar funds

Fox Run Management's Q4 2023 Portfolio in Review

As of Q4 2023, Fox Run Management held 1,089 positions worth $392M, up 16% from $338M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Fox Run Management deployed $20.5M of net new capital in Q4 2023, opening 425 new positions and adding to 148 existing holdings. Its largest new stake was Ovintiv: 39,161 shares worth $1.72M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was UGI, an estimated $1.24M trimmed.

  • Fox Run Management's largest Q4 2023 buy was Ovintiv: 39,161 shares worth $1.72M.
  • Fox Run Management added most to iShares Russell 2000 ETF in Q4 2023, an estimated $3.23M increase.
  • Fox Run Management's biggest Q4 2023 reduction was UGI, cutting an estimated $1.24M.
  • Fox Run Management fully exited iShares US Real Estate ETF in Q4 2023, selling an estimated $1.74M.
  • Fox Run Management's ten largest holdings make up 7.4% of its $392M portfolio in Q4 2023.
  • Fox Run Management opened 425 new positions and closed 399 in Q4 2023.
  • Fox Run Management's portfolio value rose 16% quarter-over-quarter to $392M.

Based on Fox Run Management's 13F filing for Q4 2023, filed 13 Feb 2024.